Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Oral Semaglutide With Matched Oral Semaglutide Placebo as an Early Treatment for Latino Adults With Type 2 Diabetes Receiving Enhanced Lifestyle Care

NCT04938388 is registered in ClinicalTrials.gov with Sansum Diabetes Research Institute as lead sponsor.

NCT NCT04938388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04938388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Oral Semaglutide With Matched Oral Semaglutide Placebo as an Early Treatment for Latino Adults With Type 2 Diabetes Receiving Enhanced Lifestyle Care
Lead sponsor
Sansum Diabetes Research Institute
Phase
Phase 4
Overall status
Terminated
Start date
January 29, 2022
Completion date
February 16, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, glucose metabolism disorders (including diabetes mellitus)